State-of-the-art Infectious Disease Response
In this presentation, our founder, Dr. Jian Han, discusses how iRepertoire’s technology has evolved from lessons learned through multiple epidemics to identify helpful antibodies with first-rate specificity, now using single-cell sequencing. Gain a personal overview of our pathway as a company, and an insider introduction to a new test we’re developing in collaboration with our sister company iCubate that aims to circumvent RNA extraction bottlenecks all-together in a smart, scalable solution.
